Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02973711
Title A Phase I/II Study of Ruxolitinib in Combination With Nilotinib in Patients With Chronic Phase CML
Recruitment Withdrawn
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors University of Michigan Cancer Center
Indications

chronic myeloid leukemia

Therapies

Nilotinib + Ruxolitinib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.